Perioperative in‐hospital adverse events; laparoconversion · women with uterine fibroids
Laparoscopic myomectomy showed no clear difference in perioperative in‐hospital adverse events; laparoconversion compared with open myomectomy (all types) (moderate certainty).
1 finding from 1 review
Perioperative in‐hospital adverse events; injury to pelvic organs · women with uterine fibroids
Laparoscopic myomectomy showed no clear difference in perioperative in‐hospital adverse events; injury to pelvic organs compared with open myomectomy (all types) (moderate certainty).
1 finding from 1 review
In‐hospital adverse events; postoperative fever · women with uterine fibroids
Laparoscopic myomectomy probably leads to lower in‐hospital adverse events; postoperative fever compared with open myomectomy (all types) (moderate certainty).
1 finding from 1 review
Satisfaction with treatment up to 24 months · patients with symptomatic uterine fibroids
Uterine artery embolization (UAE) showed no clear difference in satisfaction with treatment up to 24 months compared with surgery (moderate certainty).
1 finding from 1 review
Satisfaction with treatment at 5 years · patients with symptomatic uterine fibroids
Uterine artery embolization (UAE) showed no clear difference in satisfaction with treatment at 5 years compared with surgery (moderate certainty).
1 finding from 1 review
Live birth · patients with symptomatic uterine fibroids
It is very uncertain whether uterine artery embolization (UAE) changes live birth ‐ UAE versus myomectomy compared with surgery (very low certainty).
1 finding from 1 review
Adverse events: intra‐procedural complications · patients with symptomatic uterine fibroids
Uterine artery embolization (UAE) showed no clear difference in adverse events: intra‐procedural complications compared with surgery (low certainty).
1 finding from 1 review
Adverse events: minor post‐procedural complications within one year · patients with symptomatic uterine fibroids
Uterine artery embolization (UAE) probably leads to higher adverse events: minor post‐procedural complications within one year compared with surgery (moderate certainty).
1 finding from 1 review
Adverse events: major post‐procedural complications within one year · patients with symptomatic uterine fibroids
Uterine artery embolization (UAE) showed no clear difference in adverse events: major post‐procedural complications within one year compared with surgery (moderate certainty).
1 finding from 1 review
Further interventions within 2 years · patients with symptomatic uterine fibroids
Uterine artery embolization (UAE) probably leads to higher further interventions within 2 years compared with surgery (moderate certainty).
1 finding from 1 review
Intervention · women with uterine fibroids
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Loop ligation of myoma pseudocapsule plus vasopressin · women with uterine fibroids
Interventions to reduce blood loss during myomectomy for fibroids showed no clear difference in loop ligation of myoma pseudocapsule plus vasopressin compared with placebo or no treatment (low certainty).
1 finding from 1 review
Fibrin sealant patch (collagen sponge with thrombin and fibrinogen) · women with uterine fibroids
Interventions to reduce blood loss during myomectomy for fibroids showed no clear difference in fibrin sealant patch (collagen sponge with thrombin and fibrinogen) compared with placebo or no treatment (low certainty).
1 finding from 1 review
Blood loss (ml) Estimated blood loss during myomectomy · women with uterine fibroids
Misoprostol showed no clear difference in blood loss (ml) Estimated blood loss during myomectomy compared with placebo to reduce blood loss during myomectomy (moderate certainty).
1 finding from 1 review
Blood transfusion · women with uterine fibroids
Misoprostol showed no clear difference in need for blood transfusion Number of participants who received blood… compared with placebo to reduce blood loss during myomectomy (low certainty).
1 finding from 1 review
Operating time · women with uterine fibroids
Misoprostol showed no clear difference in duration of surgery (min) Operative time compared with placebo to reduce blood loss during myomectomy (low certainty).
1 finding from 1 review
Blood loss (ml) Estimated blood loss during myomectomy · women with uterine fibroids
Vasopressin showed no clear difference in blood loss (ml) Estimated blood loss during myomectomy compared with placebo to reduce blood loss during myomectomy (moderate certainty).
1 finding from 1 review
Blood transfusion · women with uterine fibroids
Vasopressin probably leads to lower need for blood transfusion Participants who received blood transfusion compared with placebo to reduce blood loss during myomectomy (moderate certainty).
1 finding from 1 review
Operative time · women with uterine fibroids
Vasopressin showed no clear difference in duration of surgery Operative time compared with placebo to reduce blood loss during myomectomy (moderate certainty).
1 finding from 1 review
Blood loss (ml) Estimated blood loss during myomectomy · women with uterine fibroids
Bupivicaine plus epinephrine showed no clear difference in blood loss (ml) Estimated blood loss during myomectomy compared with placebo to reduce blood loss during myomectomy (low certainty).
1 finding from 1 review